Evaluation and management of periampullary tumors.
Periampullary cancers make up 5% of all gastrointestinal cancers. The complexity of the periampullary anatomy makes determination of the origin of some of these tumors difficult. However, advances in imaging have helped with diagnosis as well as defining the extent of the lesion and its potential resectability. For many of these tumors, surgery is the recommended treatment. However, endoscopic removal is being extended to different lesions with encouraging preliminary results. Improvements in overall prognosis for periampullary tumors will be limited until diagnosis can be established earlier in the course of the disease and adjuvant therapies become more effective.
Ross
William A
WA
Department of Gastrointestinal Medicine and Nutrition, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, Houston, TX 77030, USA. wross@mdanderson.org
Bismar
Mike M
MM
D014670:Ampulla of Vater / Q000473:pathology*; D001650:Bile Duct Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000175:diagnosis* / Q000628:therapy*; D003138:Common Bile Duct Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D004379:Duodenal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans